Contact
Please use this form to send email to PR contact of this press release:
Axovant Announces Clinical Update From First Tay-Sachs Disease Patient Dosed With AXO-AAV-GM2 Gene Therapy
TO:
Please use this form to send email to PR contact of this press release:
Axovant Announces Clinical Update From First Tay-Sachs Disease Patient Dosed With AXO-AAV-GM2 Gene Therapy
TO: